Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cees C Tijssen

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Parkinsonism & Related Disorders|November 17, 2009
Myoclonus-dystonia and spinocerebellar ataxia type 14 presenting with similar phenotypes: trunk tremor, myoclonus, and dystoniaElisabeth M J Foncke, Richard J Beukers, Cees C Tijssen, et al.
Headache|February 12, 2005
Effect of low-intensity acenocoumarol on frequency and severity of migraine attacksElisabeth A Wammes-van der Heijden, Martijn H Smidt, Cees C Tijssen, et al.
Journal of Neuro-Oncology|July 26, 2019
Predicting disease progression in high-grade glioma with neuropsychological parameters: the value of personalized longitudinal assessmentElke Butterbrod, Jimme Bruijn, Meriam M Braaksma, et al.
International Journal of Clinical Pharmacy|May 30, 2013
Identification of drug-related problems by a clinical pharmacist in addition to computerized alertsRianne J Zaal, Mark M P M Jansen, Marjolijn Duisenberg-van Essenberg, et al.
Journal of Neuro-Oncology|December 14, 2017
Internet-based guided self-help for glioma patients with depressive symptoms: a randomized controlled trialFlorien W Boele, Martin Klein, Irma M Verdonck-de Leeuw, et al.
European Journal of Cancer (Oxford, England : 1990)|July 31, 2013
New clinical, pathological and molecular prognostic models and calculators in patients with locally diagnosed anaplastic oligodendroglioma or oligoastrocytoma. A prognostic factor analysis of European Organisation for Research and Treatment of Cancer Brain Tumour Group Study 26951Thierry Gorlia, Jean-Yves Delattre, Alba A Brandes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2007
Prognostic value of health-related quality-of-life data in predicting survival in patients with anaplastic oligodendrogliomas, from a phase III EORTC brain cancer group studyMurielle E L Mauer, Martin J B Taphoorn, Andrew Bottomley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2010
IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor GroupMartin J van den Bent, Hendrikus J Dubbink, Yannick Marie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2007
Health-related quality of life in patients treated for anaplastic oligodendroglioma with adjuvant chemotherapy: results of a European Organisation for Research and Treatment of Cancer randomized clinical trialMartin J B Taphoorn, Martin J van den Bent, Murielle E L Mauer, et al.
Journal of Neuro-Oncology|October 29, 2013
Health-related quality of life and cognitive functioning in long-term anaplastic oligodendroglioma and oligoastrocytoma survivorsEsther J J Habets, Martin J B Taphoorn, Sylvie Nederend, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Parkinsonism & Related Disorders|November 17, 2009
Myoclonus-dystonia and spinocerebellar ataxia type 14 presenting with similar phenotypes: trunk tremor, myoclonus, and dystoniaElisabeth M J Foncke, Richard J Beukers, Cees C Tijssen, et al.
Headache|February 12, 2005
Effect of low-intensity acenocoumarol on frequency and severity of migraine attacksElisabeth A Wammes-van der Heijden, Martijn H Smidt, Cees C Tijssen, et al.
Journal of Neuro-Oncology|July 26, 2019
Predicting disease progression in high-grade glioma with neuropsychological parameters: the value of personalized longitudinal assessmentElke Butterbrod, Jimme Bruijn, Meriam M Braaksma, et al.
International Journal of Clinical Pharmacy|May 30, 2013
Identification of drug-related problems by a clinical pharmacist in addition to computerized alertsRianne J Zaal, Mark M P M Jansen, Marjolijn Duisenberg-van Essenberg, et al.
Journal of Neuro-Oncology|December 14, 2017
Internet-based guided self-help for glioma patients with depressive symptoms: a randomized controlled trialFlorien W Boele, Martin Klein, Irma M Verdonck-de Leeuw, et al.
European Journal of Cancer (Oxford, England : 1990)|July 31, 2013
New clinical, pathological and molecular prognostic models and calculators in patients with locally diagnosed anaplastic oligodendroglioma or oligoastrocytoma. A prognostic factor analysis of European Organisation for Research and Treatment of Cancer Brain Tumour Group Study 26951Thierry Gorlia, Jean-Yves Delattre, Alba A Brandes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2007
Prognostic value of health-related quality-of-life data in predicting survival in patients with anaplastic oligodendrogliomas, from a phase III EORTC brain cancer group studyMurielle E L Mauer, Martin J B Taphoorn, Andrew Bottomley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2010
IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor GroupMartin J van den Bent, Hendrikus J Dubbink, Yannick Marie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2007
Health-related quality of life in patients treated for anaplastic oligodendroglioma with adjuvant chemotherapy: results of a European Organisation for Research and Treatment of Cancer randomized clinical trialMartin J B Taphoorn, Martin J van den Bent, Murielle E L Mauer, et al.
Journal of Neuro-Oncology|October 29, 2013
Health-related quality of life and cognitive functioning in long-term anaplastic oligodendroglioma and oligoastrocytoma survivorsEsther J J Habets, Martin J B Taphoorn, Sylvie Nederend, et al.
Pageof 3